MIRC is in the News With a New Next-Generation Trivalent SARS-CoV-2 Vaccine
The vaccine may prove to be a next generation COVID-19 strategy to induce broad mucosal immunity against current and future variants of concern (VOC) with high-efficacy in human trials.
The vaccine may prove to be a next generation COVID-19 strategy to induce broad mucosal immunity against current and future VOC with high-efficacy in human trials. McMaster Immunology Research Centre (MIRC).
Main Research, Uncategorized